載入...
The long noncoding RNA HORAS5 mediates castration‐resistant prostate cancer survival by activating the androgen receptor transcriptional program
Prostate cancer (PCa) is driven by the androgen receptor (AR)‐signaling axis. Hormonal therapy often mitigates PCa progression, but a notable number of cases progress to castration‐resistant PCa (CRPC). CRPC retains AR activity and is incurable. Long noncoding RNA (lncRNA) represent an uncharted reg...
Na minha lista:
| 發表在: | Mol Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6487714/ https://ncbi.nlm.nih.gov/pubmed/30776192 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12471 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|